Co-amoxisaph (Co-amoxiclav) is a powerful broad-spectrum antibiotic that combines Amoxicillin and Clavulanic Acid. This 625mg film-coated tablet (containing 500mg Amoxicillin and 125mg Clavulanic Acid) is specifically designed to treat bacterial infections that have developed resistance to standard penicillins. The Clavulanic Acid works by blocking the enzymes that bacteria use to defend themselves, allowing the Amoxicillin to effectively eliminate the infection.
Key Clinical Uses:
-
Respiratory Infections: Highly effective for sinusitis, tonsillitis, otitis media (ear infections), and community-acquired pneumonia.
-
Urinary Tract Infections (UTI): Targets bacteria responsible for infections in the bladder and kidneys (cystitis and pyelonephritis).
-
Skin and Soft Tissue Infections: Used to treat cellulitis, abscesses, animal bites, and infected wounds.
-
Dental Health: Frequently prescribed by dentists for severe dental abscesses and post-surgical care.
Usage & Administration:
-
Administration: To ensure maximum absorption and reduce the risk of stomach upset, take Co-amoxisaph at the start of a meal.
-
Consistency: Take the tablets at regular intervals and complete the full 21-tablet course even if you feel better within a few days. This prevents the infection from returning and reduces the risk of antibiotic resistance.
-
Storage: Store in a cool, dry place at temperatures not exceeding 30°C. Keep in the original blister packaging to protect from moisture.
Disclaimer: This is a prescription-only (Rx) medication. It must be used strictly under the professional guidance of a licensed physician.





